Laboratorios Farmaceúticos Rovi SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0157261019
EUR
59.70
1.7 (2.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
191.67
152.49
218.42
210.47
159.70
154.89
199.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
191.67
152.49
218.42
210.47
159.70
154.89
199.14
Raw Material Cost
69.84
67.78
87.66
70.13
61.88
71.78
87.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
47.22
38.04
36.02
34.66
35.32
35.09
37.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.97
0.78
0.76
0.76
0.70
0.63
0.73
Selling and Distribution Expenses
81.67
63.63
62.74
64.46
59.85
54.05
70.80
Other Expenses
-2.71
-2.76
-2.37
-2.75
-2.54
-2.95
-2.99
Total Expenditure (Excl Depreciation)
173.62
142.61
163.49
142.49
132.33
132.03
166.77
Operating Profit (PBDIT) excl Other Income
18
9.9
54.900000000000006
68
27.400000000000002
22.9
32.400000000000006
Other Income
73.16
3.05
3.72
8.40
0.06
0.80
0.62
Operating Profit (PBDIT)
101.01
21.10
66.81
83.85
34.89
30.94
40.41
Interest
1.97
0.78
0.76
0.76
0.70
0.63
0.73
Exceptional Items
0.00
0.10
0.00
0.00
0.04
-0.10
0.00
Gross Profit (PBDT)
121.82
84.72
130.76
140.34
97.82
83.12
111.57
Depreciation
9.81
8.17
8.16
7.47
7.47
7.28
7.43
Profit Before Tax
89.23
12.25
57.89
75.62
26.77
22.93
32.26
Tax
14.35
2.84
15.29
17.68
5.15
4.77
8.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
75.00
9.48
42.68
58.03
21.64
18.10
23.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
75.00
9.48
42.68
58.03
21.64
18.10
23.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.07
-0.03
-0.02
-0.02
-0.01
-0.03
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
74.93
9.45
42.65
58.01
21.62
18.08
23.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Reserves
700.62
673.91
664.41
621.74
563.63
589.87
572.03
Earnings per share (EPS)
1.47
0.19
0.83
1.13
0.42
0.35
0.46
Diluted Earnings per share
1.47
0.19
0.83
1.13
0.42
0.35
0.46
Operating Profit Margin (Excl OI)
9.42%
6.48%
25.15%
32.3%
17.14%
14.76%
16.25%
Gross Profit Margin
51.67%
13.39%
30.24%
39.48%
21.44%
19.5%
19.93%
PAT Margin
39.13%
6.22%
19.54%
27.57%
13.55%
11.69%
11.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 20.04% vs -10.38% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 246.76% vs -26.53% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is -19.83% vs -20.91% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 185.71% vs 133.33% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Laboratorios Farmaceúticos Rovi SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
191.67
1,874.00
-1,682.33
-89.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
191.67
1,874.00
-1,682.33
-89.77%
Raw Material Cost
69.84
1,170.00
-1,100.16
-94.03%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
47.22
0.00
47.22
Power Cost
0
0
0.00
Manufacturing Expenses
1.97
79.00
-77.03
-97.51%
Selling and Distribution Expenses
81.67
289.00
-207.33
-71.74%
Other Expenses
-2.71
0.70
-3.41
-487.14%
Total Expenditure (Excl Depreciation)
173.62
1,545.00
-1,371.38
-88.76%
Operating Profit (PBDIT) excl Other Income
18.05
329.00
-310.95
-94.51%
Other Income
73.16
0.00
73.16
Operating Profit (PBDIT)
101.01
436.00
-334.99
-76.83%
Interest
1.97
79.00
-77.03
-97.51%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
121.82
704.00
-582.18
-82.70%
Depreciation
9.81
107.00
-97.19
-90.83%
Profit Before Tax
89.23
250.00
-160.77
-64.31%
Tax
14.35
64.00
-49.65
-77.58%
Provisions and contingencies
0
0
0.00
Profit After Tax
75.00
154.00
-79.00
-51.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
75.00
154.00
-79.00
-51.30%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.07
29.00
-29.07
-100.24%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
74.93
183.00
-108.07
-59.05%
Equity Capital
0
0
0.00
Face Value
0.06
0.25
0.00
Reserves
700.62
5,546.00
-4,845.38
-87.37%
Earnings per share (EPS)
1.47
0.23
1.24
539.13%
Diluted Earnings per share
1.47
0.23
1.24
539.13%
Operating Profit Margin (Excl OI)
9.42%
17.56%
0.00
-8.14%
Gross Profit Margin
51.67%
19.05%
0.00
32.62%
PAT Margin
39.13%
8.22%
0.00
30.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.17 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 25.70% vs -30.17% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 20.04% vs -10.38% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.49 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 696.81% vs -77.99% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 246.76% vs -26.53% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.79 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 54.14% vs -71.32% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -19.83% vs -20.91% in Jun 2025

Quarterly - Interest
Interest 0.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 150.00% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 185.71% vs 133.33% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.42%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025